| Dr Leonard Joseph Caputo, MD | |
|
548 Boulevard Park W, B, Mobile, AL 36609-3406 | |
| (251) 304-0042 | |
| (251) 304-0262 |
| Full Name | Dr Leonard Joseph Caputo |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 548 Boulevard Park W, Mobile, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336169051 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 8384 (Alabama) | Primary |
| 208000000X | Pediatrics | 8384 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leonard Joseph Caputo, MD 548 Boulevard Park W, B, Mobile, AL 36609-3406 Ph: (251) 304-0042 | Dr Leonard Joseph Caputo, MD 548 Boulevard Park W, B, Mobile, AL 36609-3406 Ph: (251) 304-0042 |
News Archive
"Did you think we wouldn't notice?" an older woman says, speaking into the camera. "You thought you could sneak this through?" an older man later adds. Others warn that Washington is "messing with" their Medicare Advantage health coverage and trying to raise their premiums.
Small non-coding RNAs can be used to predict if individuals have breast cancer conclude researchers who contribute to The Cancer Genome Atlas project. The results, which are published in EMBO reports, indicate that differences in the levels of specific types of non-coding RNAs can be used to distinguish between cancerous and non-cancerous tissues. These RNAs can also be used to classify cancer patients into subgroups of individuals that have different survival outcomes.
New research by the Twins and Multiple Births Association (Tamba) has found that nearly 50 per cent of parents are left struggling unsupported after the birth.
Intellipharmaceutics International Inc. today announced that Novartis Pharmaceuticals Corporation and Celgene Corporation have settled their patent suit in the U.S. District Court for the District of New Jersey, and Elan Pharma International Ltd. has settled its patent suit in the U.S. District Court for the District of Delaware, with Intellipharmaceutics Corp., a wholly-owned subsidiary of Intellipharmaceutics International, and its licensee Par Pharmaceutical, Inc. over a generic version of the Attention Deficit Hyperactivity Disorder drug Focalin XR® (dexmethylphenidate hydrochloride).
› Verified 5 days ago
Ladonna M. Crews, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1601 Center St, Ste 1n, Mobile, AL 36604 Phone: 251-410-5437 Fax: 251-434-3802 | |
Charlotte Steelman Macdonell, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1601 Center St Ste 1n, Mobile, AL 36604 Phone: 251-410-5437 Fax: 251-434-3802 | |
Dr. Kalsang Dolma, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1700 Center St, Mobile, AL 36604 Phone: 251-415-1055 Fax: 251-415-1045 | |
Mrs. Robin C Mcnair, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3719 Dauphin St, Ste 102, Mobile, AL 36608 Phone: 251-344-1502 Fax: 251-342-1116 | |
Daniel T Mccall Iii, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 248 Cox St, Suite A, Mobile, AL 36604 Phone: 251-405-4524 Fax: 251-405-4521 | |
Dr. Stephanie Jeanine Anderson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1601 Center St, Mobile, AL 36604 Phone: 251-410-5437 Fax: 251-415-8578 | |
Dr. Ananthasekar Ponnambalam, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1601 Center Street, Suite 1s, Mobile, AL 36604 Phone: 251-410-5437 Fax: 251-434-3852 |